Zydus Wellness FY26 Results: Revenue up 46%, debt hits ₹30,711 crore

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Revenue rose 46.2% YoY to ₹36,610 million in FY26
  • EBITDA grew 34.2% to ₹5,097 million
  • Net profit declined due to higher finance costs and amortization from Comfort Click acquisition
  • Total borrowings increased to ₹30,711 million, funded at ~5% interest
  • Board declared a dividend of ₹1.20 per share
powered bylight_fuzz_icon
49905857

*this image is generated using AI for illustrative purposes only.

Zydus Wellness reported a 46.2% rise in revenue from operations to ₹36,610 million for FY26, driven by strong performance in its skincare and haircare portfolios and international expansion.

The company’s EBITDA grew 34.2% to ₹5,097 million. However, net profit declined due to higher finance costs and depreciation following the acquisition of Comfort Click Limited. The board declared a dividend of ₹1.20 per equity share.

Financial Performance

Zydus Wellness navigated seasonal headwinds in domestic categories while leveraging its global footprint. International business, including the newly acquired Comfort Click, contributed more than 30% of total revenue.

Metric FY26 Figure Growth
Revenue from Operations ₹36,610 million +46.2%
EBITDA ₹5,097 million +34.2%
Dividend per Share ₹1.20 -

Balance Sheet & Acquisition Impact

The acquisition of Comfort Click Limited, which includes subsidiaries in Ireland, India, and the United States, significantly altered the company’s balance sheet structure. Total borrowings rose to approximately ₹30,711 million, largely funded by GBP-denominated debt at interest rates around 5%.

CFO Umesh Parikh noted that the decline in net profit was primarily attributable to:

  • Higher finance costs associated with the new debt.
  • Increased depreciation and amortization charges from the acquisition.
  • Deal-related costs recorded in the period.

Management plans to repay the liability over a period of five and a half to seven years. The goodwill recorded from the acquisition has been tested annually, with auditors confirming that the recorded value remains lower than the underlying business value.

What the Numbers Show

Revenue growth outpaced EBITDA expansion by over 12 percentage points (46.2% vs 34.2%), suggesting margin compression or a shift toward lower-margin segments within the new portfolio. This divergence is consistent with the integration of a digital-first, direct-to-consumer business like Comfort Click, which typically carries different cost structures compared to traditional FMCG distribution models.

Strategic Outlook

Chairman Dr. Sharvil P. Patel highlighted the resilience of iconic brands such as Sugar Free, Glucon-D, and Complan. The company is focusing on premiumisation and science-led innovation to counteract seasonal volatility in domestic sales. Approximately 30% of the business is now driven by modern trade, e-commerce, and quick commerce channels.

The company also received recognition in the S&P Global Sustainability Yearbook 2026 and was named among India’s Best Workplaces in FMCG for the fourth consecutive year.

Historical Stock Returns for Zydus Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%+1.74%-7.44%+38.89%+20.52%+14.93%

How will the integration of Comfort Click's digital-first model impact Zydus Wellness' long-term operating margins compared to its traditional FMCG distribution channels?

What is the company's strategy for managing currency risk exposure given that a significant portion of its new debt is GBP-denominated?

Will Zydus Wellness prioritize debt repayment through organic cash flows or consider equity dilution to strengthen its balance sheet over the next 5-7 years?

Zydus Wellness appoints Kapil Sharma as CRO effective September 1, 2026

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Zydus Wellness appoints Kapil Sharma as CRO for India and Indian subcontinent
  • Appointment effective September 1, 2026, approved by Board of Directors
  • Sharma brings 28+ years experience, including 25 years at P&G
  • Previously served as VP-Gillette, India and Indian subcontinent
powered bylight_fuzz_icon
49782004

*this image is generated using AI for illustrative purposes only.

Zydus Wellness Limited has appointed Kapil Sharma as its Chief Revenue Officer (India and Indian subcontinent), effective September 1, 2026. The Board of Directors approved the appointment following the recommendation of the Nomination and Remuneration Committee.

Leadership appointment details

The following table summarises the key details of the appointment:

Parameter Details
Appointee Kapil Sharma
New Role Chief Revenue Officer (India and Indian subcontinent)
Effective Date September 1, 2026
Previous Role VP at Gillette within P&G

Sharma brings over 28 years of experience to the role, including 25 years with Procter & Gamble. He most recently served as VP-Gillette, India and Indian subcontinent, leading the grooming portfolio comprising Gillette, Venus, and Braun. Earlier in his career, he worked with Asea Brown Boveri for three years.

He holds an MBA in Marketing from S.P. Jain Institute of Management & Research, Mumbai, and a Bachelor of Electrical Engineering from the Institute of Engineering & Technology, Lucknow.

Historical Stock Returns for Zydus Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%+1.74%-7.44%+38.89%+20.52%+14.93%

How is Zydus Wellness expected to leverage Kapil Sharma's FMCG expertise to accelerate revenue growth in the competitive Indian wellness market?

What specific strategic shifts or new product initiatives might Sharma introduce given his background in leading the Gillette and Braun grooming portfolios?

Could this appointment signal a broader strategic pivot for Zydus Wellness towards mass-market consumer goods rather than just niche wellness products?

More News on Zydus Wellness

1 Year Returns:+20.52%